Futura Medical Cash Flow Conversion Efficiency

Latest as of December 2025: -0.940x

Futura Medical cash flow conversion efficiency. Based on the latest financial reports, Futura Medical (FUM) has a cash flow conversion efficiency ratio of -0.940x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.64 Million ≈ $-320.73 USD) by net assets (GBX2.81 Million ≈ $341.31 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Futura Medical (2001–2025)

Cash flow conversion efficiency of Futura Medical from 2001 to 2025. This chart illustrates how Futura Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Futura Medical for real-time trading data and today's change.

Futura Medical Cash Flow Conversion Ratio Explained

Futura Medical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Futura Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Futura Medical ranked by their cash flow conversion efficiency. Also see FUM stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Distil Plc LSE:DIS	-0.129x
Eenergy Group PLC LSE:EAAS	1.306x
Ordinary Fully Paid Deferred Settlement AU:BCNDA	0.080x
MediaZest plc LSE:MDZ	0.255x
CRESTVIEW EXPLORATION INC F:CE7	N/A
SRAX Inc NASDAQ:SRAX	0.394x
Eos Energy Enterprises Inc NASDAQ:EOSEW	0.028x
t42 IoT Tracking Solutions PLC LSE:TRAC	-0.185x

Annual Cash Flow Conversion Efficiency for Futura Medical (2001–2025)

The table below shows the annual cash flow conversion efficiency of Futura Medical from 2001 to 2025. Review free cash flow generation of Futura Medical to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX2.81 Million ≈ $341.31	GBX-5.58 Million ≈ $-678.54	-1.988x	-4164.32%
2024-12-31	GBX8.96 Million ≈ $1.09K	GBX438.41K ≈ $53.34	0.049x	-53.02%
2023-12-31	GBX5.48 Million ≈ $666.37	GBX570.25K ≈ $69.38	0.104x	+108.51%
2022-12-31	GBX4.72 Million ≈ $574.23	GBX-5.78 Million ≈ $-702.69	-1.224x	-207.24%
2021-12-31	GBX9.72 Million ≈ $1.18K	GBX-3.87 Million ≈ $-471.26	-0.398x	+92.52%
2020-12-31	GBX853.54K ≈ $103.85	GBX-4.54 Million ≈ $-552.79	-5.323x	+95.71%
2019-12-31	GBX53.65K ≈ $6.53	GBX-6.66 Million ≈ $-809.87	-124.063x	-23226.94%
2018-12-31	GBX8.85 Million ≈ $1.08K	GBX-4.71 Million ≈ $-572.83	-0.532x	-16.00%
2017-12-31	GBX9.11 Million ≈ $1.11K	GBX-4.17 Million ≈ $-507.95	-0.458x	-74.94%
2016-12-31	GBX12.58 Million ≈ $1.53K	GBX-3.30 Million ≈ $-401.27	-0.262x	+76.61%
2015-12-31	GBX4.79 Million ≈ $582.35	GBX-5.36 Million ≈ $-652.63	-1.121x	-255.27%
2014-12-31	GBX9.72 Million ≈ $1.18K	GBX-3.07 Million ≈ $-373.13	-0.315x	+84.53%
2013-12-31	GBX987.77K ≈ $120.18	GBX-2.01 Million ≈ $-245.04	-2.039x	-201.85%
2012-12-31	GBX2.87 Million ≈ $349.59	GBX-1.94 Million ≈ $-236.14	-0.675x	-1.47%
2011-12-31	GBX2.76 Million ≈ $335.57	GBX-1.84 Million ≈ $-223.39	-0.666x	+42.71%
2010-12-31	GBX901.00K ≈ $109.63	GBX-1.05 Million ≈ $-127.39	-1.162x	-63.37%
2009-12-31	GBX1.85 Million ≈ $225.46	GBX-1.32 Million ≈ $-160.36	-0.711x	+68.03%
2008-12-31	GBX886.00K ≈ $107.80	GBX-1.97 Million ≈ $-239.81	-2.225x	-170.33%
2007-12-31	GBX2.77 Million ≈ $337.39	GBX-2.28 Million ≈ $-277.65	-0.823x	-75.43%
2006-12-31	GBX3.95 Million ≈ $480.36	GBX-1.85 Million ≈ $-225.33	-0.469x	+56.29%
2005-12-31	GBX1.98 Million ≈ $240.91	GBX-2.12 Million ≈ $-258.55	-1.073x	-177.22%
2004-12-31	GBX3.75 Million ≈ $456.02	GBX-1.45 Million ≈ $-176.54	-0.387x	+31.27%
2003-12-31	GBX2.41 Million ≈ $293.11	GBX-1.36 Million ≈ $-165.11	-0.563x	+19.43%
2003-01-31	GBX1.52 Million ≈ $184.82	GBX-1.06 Million ≈ $-129.21	-0.699x	-8.85%
2002-01-31	GBX2.00 Million ≈ $243.22	GBX-1.28 Million ≈ $-156.23	-0.642x	-159.76%
2001-01-31	GBX-294.00K ≈ $-35.77	GBX-316.00K ≈ $-38.45	1.075x	--

About Futura Medical

LSE:FUM UK Biotechnology

Market Cap

$14.78K

GBX121.50 Million GBX

Market Cap Rank

#31830 Global

#1281 in UK

Share Price

GBX0.21

Change (1 day)

+10.58%

52-Week Range

GBX0.16 - GBX2.45

All Time High

GBX84.52